HCA Healthcare (HCA)
(Delayed Data from NYSE)
$415.54 USD
+9.06 (2.23%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $415.66 +0.12 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$415.54 USD
+9.06 (2.23%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $415.66 +0.12 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Zacks News
Boston Scientific's (BSX) Watchman US Sale to Aid Q1 Earnings
by Zacks Equity Research
Within Boston Scientific's (BSX) coronary therapies, drug-eluting stents sale continue to be a challenge from a pricing standpoint in Q1.
Integra (IART) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
The acquisition of ACell, and faster recovery growth rate in Japan and China are likely to have helped recover Integra's first-quarter 2021 performance.
HCA Healthcare's (HCA) Q1 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) first-quarter results highlight higher revenues, partly offset by increased costs.
HCA Holdings (HCA) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of 23.58% and 2.19%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for HCA Healthcare (HCA) This Earnings Season?
by Zacks Equity Research
HCA Healthcare (HCA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
VITUS to Hurt Chemed (CHE) Q1 Earnings, Roto-Rooter to Aid
by Zacks Equity Research
The federal government's recent approach in terms of relaxing regulations, allowing broader use of telehealth, is likely to have helped in some sort of recovery of Chemed's (CHE) VITAS business in Q1.
Illumina (ILMN) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Illumina (ILMN) is likely to have gained during the first quarter on the back of robust performance of the sequencing consumable segment.
Amedisys (AMED) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Growth in Home Health and Hospice along with recent innovation and acquisitions is expected to have contributed to Amedisys (AMED) top-line growth in Q1.
What's in Store for HCA Healthcare's (HCA) Q1 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) first-quarter earnings are likely to have witnessed better patient volumes and improved revenues.
Molecular Tests to Drive Quest Diagnostics (DGX) Q1 Earnings
by Zacks Equity Research
Through the first quarter, Quest Diagnostics' (DGX) several significant strides in the field of COVID-19 diagnostic testing are expected to have contributed to the top line.
Anthem (ANTM) to Report Q1 Earnings: What's in its Store?
by Zacks Equity Research
Anthem's (ANTM) first-quarter earnings to reflect better revenues and higher membership.
Zacks.com featured highlights include: East West Bancorp, HCA Healthcare, Microsoft and T. Rowe Price
by Zacks Equity Research
Zacks.com featured highlights include: East West Bancorp, HCA Healthcare, Microsoft and T. Rowe Price
Zacks.com featured highlights include: East West Bancorp, HCA Healthcare, Microsoft and T. Rowe Price
by Zacks Equity Research
Zacks.com featured highlights include: East West Bancorp, HCA Healthcare, Microsoft and T. Rowe Price
HCA Holdings (HCA) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
HCA (HCA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Earnings ESP: A Better Way to Find Earnings Surprises for Medical
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
4 GARP Stocks for a Winning Portfolio
by Shilpa Mete
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
3 Reasons Why HCA (HCA) Is a Great Growth Stock
by Zacks Equity Research
HCA (HCA) could produce exceptional returns because of its solid growth attributes.
The Zacks Analyst Blog Highlights: Whirlpool Corp, Olympic Steel, KB Home, Dillard's and HCA Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Whirlpool Corp, Olympic Steel, KB Home, Dillard's and HCA Healthcare
6 Growth Stocks with Tailwinds
by Sejuti Banerjea
These stocks have the potential to post positive surprises that are usually followed by share price appreciation.
UnitedHealth (UNH) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
UnitedHealth's (UNH) first-quarter results are likely to reflect well-performing UnitedHealthcare and Optum businesses, partly offset by elevated expenses related to COVID-19 pandemic.
Demand for Nutrition Line to Drive Abbott (ABT) Q1 Earnings
by Zacks Equity Research
Two additional regulatory approvals in Europe are expected to have widened Abbott's (ABT) global Panbio customer base through Q1, contributing to the top line.
THC Pitted Against CYH: Which is a Better-Positioned Stock?
by Zacks Equity Research
Both Tenet Healthcare (THC) and Community Health (CYH) are poised to grow in the thriving hospital industry. On comparative evaluation, we try to discover which stock has better chances of prosperity.
Here's Why Investors Should Hold on to Ensign Group (ENSG)
by Zacks Equity Research
Riding high on growing top line and strategic measures, Ensign Group (ENSG) holds potential to reap benefits for investors.
Encompass Health (EHC) Takes Nationwide Hospital Count to 139
by Zacks Equity Research
Encompass Health (EHC) opens an inpatient rehabilitation hospital in Florida, which highlights its efforts to offer enhanced rehabilitative care in the state.
Ensign Group (ENSG) Expands in Colorado With Recent Buyouts
by Zacks Equity Research
Ensign Group (ENSG) penetrates the Colorado market with predominance via a host of acquisitions.